{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:11:51Z","timestamp":1792300311594,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.urolonc.2019.09.010","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T08:22:26Z","timestamp":1571300546000},"page":"80.e1-80.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Ethnic disparities among men with prostate cancer undergoing germline testing"],"prefix":"10.1016","volume":"38","author":[{"given":"Daniel Hyuck-Min","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala T.","family":"Borno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather H.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia Yiran","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Jay","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2019.09.010_bib0001","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Familial risk and heritability of cancer among twins in Nordic countries","volume":"315","author":"Mucci","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0003","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nrurol.2013.266","article-title":"The genetic epidemiology of prostate cancer and its clinical implications","volume":"11","author":"Eeles","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0004","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","article-title":"Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci","volume":"50","author":"Schumacher","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41568-018-0087-3","article-title":"Post-GWAS in prostate cancer: from genetic association to biological contribution","volume":"19","author":"Farash","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0006","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/bjc.2012.146","article-title":"Germline BRCA1 mutations increase prostate cancer risk","volume":"106","author":"Leongamornlert","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0007","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1086\/346094","article-title":"Mutations in CHEK2 associated with prostate cancer risk","volume":"72","author":"Dong","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0008","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.bjc.6602007","article-title":"ATM polymorphisms as risk factors for prostate cancer development","volume":"91","author":"Ang\u00e8le","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0009","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/jmedgenet-2016-103839","article-title":"PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS","volume":"53","author":"Southey","year":"2016","journal-title":"J Med Genet"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJMoa1110000","article-title":"Germline mutations in HOXB13 and prostate-cancer risk","volume":"366","author":"Ewing","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0011","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-repair gene mutations in men with metastatic prostate cancer","volume":"375","author":"Pritchard","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0012","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Prostate Cancer Version 2.2019","author":"Mohler","year":"2019"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0013","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.74.1173","article-title":"Role of genetic testing for inherited prostate cancer risk: Philadelphia Prostate Cancer Consensus Conference 2017","volume":"36","author":"Giri","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00060","article-title":"Evolving intersection between inherited cancer genetics and therapeutic clinical trials in prostate cancer: a white paper from the germline genetics working group of the Prostate Cancer Clinical Trials Consortium","volume":"2","author":"Carlo","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0015","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamaoncol.2018.6760","article-title":"Prevalence of germline variants in prostate cancer and implications for current genetic testing guidelines","volume":"5","author":"Nicolosi","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0016","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/pros.23739","article-title":"Germline genetic testing for inherited prostate cancer in practice: implications for genetic testing, precision therapy, and cascade testing","volume":"79","author":"Giri","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0017","first-page":"275","article-title":"A scalable, aggregated genotypic-phenotypic database for human disease variation","volume":"17","author":"Barrett","year":"2019","journal-title":"Database"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2019.5670","article-title":"Emergence of hybrid models of genetic testing beyond direct-to-consumer or traditional labs","author":"Phillips","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0019","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0020","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.6593","article-title":"Clinical utility and reimbursement for expanded genomic panel testing in adult oncology","volume":"37","author":"Hsiao","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0021","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/cge.13228","article-title":"Spectrum of APC and MUTYH germ-line mutations in Russian patients with colorectal malignancies","volume":"93","author":"Yanus","year":"2018","journal-title":"Clin Genet"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0022","series-title":"U.S. Cancer Statistics Data Visualizations Tool, based on November 2017 submission data (1999-2015): U.S. Department of Health and Human Services","year":"2018"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0023","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/gtmb.2013.1548","article-title":"The need to build trust: a perspective on disparities in genetic testing","volume":"17","author":"Saulsberry","year":"2013","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0024","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ng1096-185","article-title":"Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2","volume":"14","author":"Roa","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cancergen.2015.12.013","article-title":"Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort","volume":"209","author":"Ricker","year":"2016","journal-title":"Cancer Genet"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0026","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/gim.2015.166","article-title":"Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing","volume":"18","author":"Susswein","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0027","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/pon.1467","article-title":"Distress among women receiving uninformative BRCA1\/2 Results: 12-month outcomes","volume":"18","author":"O'Neill","year":"2012","journal-title":"Psychooncology"},{"key":"10.1016\/j.urolonc.2019.09.010_bib0028","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2018.13152","article-title":"Prevalence of variant reclassification following hereditary cancer genetic testing","volume":"320","author":"Mersch","year":"2018","journal-title":"JAMA"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919303618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919303618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:17:37Z","timestamp":1761041857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143919303618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1078143919303618"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.09.010","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethnic disparities among men with prostate cancer undergoing germline testing","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}